Kyverna Therapeutics is a patient-centered biopharmaceutical company specializing in cell therapies for autoimmune diseases. Their lead product candidate, KYV-101, is advancing through clinical trials for conditions like stiff-person syndrome, multiple sclerosis, and myasthenia gravis. Kyverna's pipeline also includes next-generation CAR T-cell therapies targeting B cell-driven autoimmune disorders.
Kyverna Therapeutics is seeking a highly experienced Scientific Advisor to support evaluation of emerging CAR T and immune cell engineering technologies. This consultant will serve as a subject matter expert, providing independent scientific assessment of internal platform development strategies, external platforms, technologies, and partnership opportunities.
Kyverna Therapeutics is a patient-centered biopharmaceutical company specializing in cell therapies for autoimmune diseases. Their lead product candidate, KYV-101, is advancing through clinical trials for conditions like stiff-person syndrome, multiple sclerosis, and myasthenia gravis. Kyverna's pipeline also includes next-generation CAR T-cell therapies targeting B cell-driven autoimmune disorders.
TwoStep Therapeutics